Management and outcome of primary CNS lymphoma in the modern era

Caroline Houillier, Carole Soussain, Hervé Ghesquières, +55

Neurology

Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial

Jaime Gállego Pérez‐Larraya, François Ducray, Olivier Chinot, +14

Journal of Clinical Oncology

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004

Luc Bauchet, Hélène Mathieu‐Daudé, Pascale Fabbro-Péray, +28

Neuro-Oncology

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Thomas Graillon, Marc Sanson, Chantal Campello, +19

Clinical Cancer Research

French brain tumor data bank: Methodology and first results on 10,000 cases

Luc Bauchet, Valérie Rigau, Hélène Mathieu‐Daudé, +14

Journal of Neuro-Oncology

Neuro-oncologyNeuroimaging BiomarkersPediatric Brain TumorsMedicineNeuroimaging +10

Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life

Marie Blonski, Luc Taillandier, Guillaume Herbet, +12

Journal of Neuro-Oncology

Neuro-oncologySurgical OncologyGliomaMedicineCancer Management +11

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression

Germán Reyes-Botero, Caroline Dehais, Ahmed Idbaïh, +75

Neuro-Oncology

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

Khê Hoang‐Xuan, Roch Houot, Carole Soussain, +28

Blood

Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads

Karine Baumstarck, Olivier Chinot, Émeline Tabouret, +6

Health and Quality of Life Outcomes

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

Germán Reyes-Botero, Stéphanie Cartalat‐Carel, Olivier Chinot, +17

The Oncologist